ACTU·005083100·US·equity·Healthcare - Biotechnology-Activist
ACTU (Actuate Therapeutics, Inc.) is held by 29 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($3.2M), BlackRock, Inc. ($2.6M), GEODE CAPITAL MANAGEMENT, LLC ($1.3M). Net institutional sentiment: Bullish.
See how ACTU's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer